Protein S100A8/A9: A Potential New Biomarker for Pancreatic Diseases
Journal: International Journal of Clinical Endocrinology and Metabolism (Vol.3, No. 1)Publication Date: 2017-12-07
Authors : El Gammal AT Sturm JH Pinnschmidt HO Hofmann BT Bellon E et al;
Page : 023-028
Keywords : ;
Abstract
Objectives: S100A8/A9 expression has been linked to carcinogenesis and inflammation.We hypothesized that S100A8/A9 protein serum levels are a useful stratification marker for patients with pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) or chronic pancreatitis (CP).
Other Latest Articles
- Metabolic Effects of D-Chiro-Inositol and Myo-Inositol in Polycystic Ovary Syndrome
- Diabetic Retinopathy: Focus on Minority Populations
- Hyperparathyroidism and Asthenia. A New Deal?
- Preparation and Application of two Monoclonal Antibodies against Canine Parvovirus Vaccine and Field Strains
- Construction of Indonesian-Strain Avian Flu Virus Seed Vaccine Using Low Pathogenic Hemagglutinin Gene and Neuraminidase Pr8 Gene through Reverse Genetics
Last modified: 2019-01-11 18:03:00